NeuroCytonix Mexico was established in 2018 and operates a state-of-the-art clinical center in compliance with FDA guidelines for "Good Clinical Practice" (GCP).
The NeuroCytonix Mexico center is based out of Monterrey, the capital city of the state of Nuevo Leon, Mexico. The city is set in the spectacular Sierra Madre, a mountain region of northwest Mexico.
Our Monterrey clinical facility is strategically located at ‘The Center for Research and Development’ in Health Sciences (CIDICS) at the Universidad Autónoma de Nuevo León an institution that provides academic and research infrastructure in the fields of health and biomedicine.
Dr. J. Roberto Trujillo was instrumental in creating this center, where he has trained and directed an outstanding clinical research team that is currently overseeing the FDA trials.
Our facility is spread across two floors and is well equipped and designed to manage patients who require specialized assistance. We have a highly skilled team of professionals certified to conduct FDA-regulated clinical trials. Our team ensures that patients participating in clinical trials receive the highest level of care.
Our first FDA-regulated, double-blind, randomized, placebo-controlled clinical trial for children with cerebral palsy was successfully conducted at the Mexico Center. The clinical trial measured the safety and efficacy of our biomedical technology.
NeuroCytonix Mexico, S.A. DE C.V.
CIDICS, Universidad Autónoma de Nuevo León
Carlos Canseco, Colonia Mitras,
Monterrey Nuevo León, C.P 64460